LIVE Q&A
Submit your questions ahead of time via , and see below for what we've got queued up to start.
|
Hedgeye House Call + Q&A | The Doctor is In | March 7 @ 2 PM | Title Please join us on Monday, March 7 at 2 PM ET - Add to Outlook Health Care Subscribers: CLICK HERE for event details (including video, materials links, and Q&A box) |
THEME & TICKER UPDATES For Monday
Position Monitor | We'll review updates from 4Q21 earnings, new and existing ideas, and how our rankings are changing for our Watchlist, Bench, and Best Ideas. Key to some will be the updates to key company trackers. We'll also be reviewing our outlook for key Health Care ETFs, including ARKG, XLV, XHS, XHE, XBI, and how the Quad Playbook is shaping their outlooks.
Quad Playbook | So much of the individual stock performance over the last 2 years, both good and bad, has come as a consequence of very large and very consequential macro trends. While company fundamentals matter, the contribution from one more fundamental data point, one more anecdote, has been in steady decline. To adapt we're finding those ways to more tightly integrate our process with the Hedgeye Quad Playbook, because even perfect information on a company information is no guarantee of success, and less than perfect is punished severely. We'll review our revamped and evolving process that strives to connect the highest levels of macro to the specific details at the individual company level and how that marriage results in higher probability situations.
Macro Updates | In Quad 4, both GDP and Inflation slow, but Health Care tends to perform well. With COVID suppressing medical care for 2 years and Omicron almost completely faded, the US Medical Economy appears on the cusp of meaningful acceleration, giving an already positive set macro backdrop, the added tailwind for a run. But labor is tight, wages are rising for clinical staff, and not everyone will be able to benefit.
Q&A| As always the best part is the question and answer session. We learn a lot in answering. Please feel free to send your questions in ahead of time and we'll make sure they are in the queue and asked and answered.
As always, all data available upon request, and reach out to with any inquiries.
Thomas Tobin
Managing Director
Twitter
LinkedIn
